Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care for Moderate COVID-19
TCTR20220427005Phase 4Recruiting
- Sponsor
- Dr. Anucha Apisarnthanarak
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivermectin, favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Dr. Anucha Apisarnthanarak. Started Oct 2021; status: recruiting.
02
Drugs
ivermectinfavipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20220427005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220427005.